Real-Life Effectiveness and Tolerance of Upadacitinib for Severe Atopic Dermatitis in Adolescents and Adults.

Axel De GreefPierre-Dominique GhislainLaurence de MontjoyeMarie Baeck

Published in: Advances in therapy (2023)

This real-life study confirms the effectiveness of upadacitinib, particularly for the treatment of atopic dermatitis recalcitrant to conventional systemic agents, biologics or baricitinib. Induced lipid changes require close follow-up.

Keyphrases

atopic dermatitis
randomized controlled trial
systematic review
young adults
drug induced
high glucose
diabetic rats
early onset
endothelial cells
combination therapy